Objectives: Show a new user interface: 3D projection with Augmented Reality (AR) developed in our institution from high resolution breast MRI.
• learn about new applications of 3D breast MRI with AR in the therapeutic management of subclinical breast cancer.
• Show an example of applications of 3D MRI with RA to improve a lumpectomy without conventional pre-operative identification, with the choice of an optimal incision
• Show an example of an application of 3D angioscanner with RA for the identification of the deep inferior epigastric perforator vessels.
Introduction: • A 3D model with Augmented Reality can be produced from breast MRI exams with optimal resolution, in particular an isotropic voxel.
• In the case of pre-operative guidance, examinations in the treatment position can be carried out.
• Technological improvements are coming (software, smart glasses, etc.) which will allow many other applications (in surgery, radiotherapy, etc.) in the treatment of breast pathologies, but also in other pathologies.
Materials / method: A 3D and Augmented Reality (AR) model of a breast MRI has been developed by our radiosurgical teams. We present an application of a 3D MRI with RA for the identification of a subclinical breast tumor in the operating room, with a preoperative MRI in the operating position in the supine position.
Results: The surgical approach is then determined by the surgeon with less detachment of the breast tissue and complications, with a more aesthetic incision compared to an intervention with usual spotting by harpoon. A 3D CT angiography application with RA in flap breast reconstructions is also on display.
Conclusion: Augmented reality could help the surgeon perform breast lumpectomies for subclinical cancers by reducing the size of the incisions and cutaneous-glandular detachments.
Disclosures
Did you receive any funding to support your research for this TOPIC?
No
Were you provided with any honoraria, payment or other compensation for your work on this study?
No
Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No
Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No
This work was not supported by any direct or non direct funding. It is under the author's own responsability